Skip to main content

ADVERTISEMENT

Brendan Hare, PhD

Currently, there are no effective pharmacotherapies approved for experiential negative symptoms (ENS) of schizophrenia. Digital therapeutics (DTx) may represent a feasible option given ub...
10/26/2023